If the government says cancer drugs aren't worth the cost, then what? Ask drugmakers to cut their prices. After the U.K.'s National Institute for Health and Clinical Excellence rejected four kidney-cancer treatments yesterday, advocates immediately ramped up pressure on pharmaceutical companies to lower their price tags. Report [1]
Links:
[1] http://www.ft.com/cms/s/0/d0d57d92-64d3-11dd-af61-0000779fd18c.html